Prognostic Factors in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck

Gideon Bachar, Aviram Mizrachi*, Naomi Rabinovics, Dan Guttman, Thomas Shpitzer, Dean Ad-El, Tuvia Hadar

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Metastatic cutaneous squamous cell carcinoma (SCC) of the head and neck poses a significant therapeutic challengedue to its aggressive biologic behavior. We conducted a retrospective study of71 patients—58 men and 13 women, aged 28 to 88 years (mean: 71)—who had been treated atour university-affiliated tertiary care medical center for metastatic cutaneous SCCover a 15-year period. In addition to demographic data, we compiled and analyzed information on tumor characteristics, the site and extent of metastasis, treatment, follow-up, and outcome. Among the tumor factors, poorly differentiated carcinoma was an independent predictor of poorer disease-free survival, and olderage was found to be an independent predictor of poorer overall survival. We found no significant difference in disease-free or disease-specific survival among patients with parotid involvement, neck involvement, or both. In our series, the site of nodal involvement appeared to have no prognostic significance in patients with metastatic cutaneous SCC of the head and neck.

Original languageEnglish
Pages (from-to)1-10
Number of pages10
JournalEar, Nose and Throat Journal
Issue number10-11
StatePublished - 1 Oct 2016


Dive into the research topics of 'Prognostic Factors in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck'. Together they form a unique fingerprint.

Cite this